ConductScience.org, home

Paper40239010

An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update.

Roy S and 8 others. Epigenetics, 2025. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update. Papers, record 40239010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40239010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An overview of potential of natural compounds to regulate epigenetic modifications in colorectal cancer: a recent update.
PubMed
Journal
Epigenetics
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
7.18, provisional
iCite
Revised in PubMed
2026-01-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Roy SSusmitahttps://orcid.org/0009-0001-7908-1776
2Deka DDikshitahttps://orcid.org/0000-0001-5087-9023
3Kondaveeti SBSuresh Babuhttps://orcid.org/0000-0001-5183-8397
4Ayyadurai PPavithra
5Siripragada SSravani
6Philip NNeha
7Pathak SSurajithttps://orcid.org/0000-0002-7306-1272
8Duttaroy AKAsim Khttps://orcid.org/0000-0003-1619-3778
9Banerjee AAntarahttps://orcid.org/0000-0002-5519-6878

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
Epigenesis, GeneticMajor topic
Biological ProductsMajor topic
Humans
DNA Methylation
Quercetin
Isothiocyanates
Catechin
Sulfoxides

Source PubMed

Download CSV of topics

References152

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130605237MicroRNA replacement therapy in cancer.J Cell Physiol2019https://conductscience.org/library/papers/30605237PubMed
232507446A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial.Complement Ther Med2020https://conductscience.org/library/papers/32507446PubMed
337446908Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications.Molecules2023https://conductscience.org/library/papers/37446908PubMed
429547900DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.Carcinogenesis2018https://conductscience.org/library/papers/29547900PubMed
534289845Genistein as a regulator of signaling pathways and microRNAs in different types of cancers.Cancer Cell Int2021https://conductscience.org/library/papers/34289845PubMed
633631231Natural products in the reprogramming of cancer epigenetics.Toxicol Appl Pharmacol2021https://conductscience.org/library/papers/33631231PubMed
733686176Dynamic roles of inflammasomes in inflammatory tumor microenvironment.NPJ Precis Oncol2021https://conductscience.org/library/papers/33686176PubMed
8356299143,3'-Diindolylmethane Enhances Fluorouracil Sensitivity via Inhibition of Pyrimidine Metabolism in Colorectal Cancer.Metabolites2022https://conductscience.org/library/papers/35629914PubMed
931058532Cucurbitacin B inhibits cell proliferation and induces cell apoptosis in colorectal cancer by modulating methylation status of BTG3.Neoplasma2019https://conductscience.org/library/papers/31058532PubMed
1026703571The Role of Sulforaphane in Epigenetic Mechanisms, Including Interdependence between Histone Modification and DNA Methylation.Int J Mol Sci2015https://conductscience.org/library/papers/26703571PubMed
1128176652Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.Curr Cancer Drug Targets2018https://conductscience.org/library/papers/28176652PubMed
1231214247Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects.Front Genet2019https://conductscience.org/library/papers/31214247PubMed
1334001246Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy.Clin Epigenetics2021https://conductscience.org/library/papers/34001246PubMed
1437686423Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.Int J Mol Sci2023https://conductscience.org/library/papers/37686423PubMed
1528989978The therapeutic potential of resveratrol: a review of clinical trials.NPJ Precis Oncol2017https://conductscience.org/library/papers/28989978PubMed
1632903500Natural Products Impacting DNA Methyltransferases and Histone Deacetylases.Front Pharmacol2020https://conductscience.org/library/papers/32903500PubMed
1731633039Precision treatment in colorectal cancer: Now and the future.JGH Open2019https://conductscience.org/library/papers/31633039PubMed
1839725830Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies.Mol Biomed2024https://conductscience.org/library/papers/39725830PubMed
1934235089Remodeling the Epigenetic Landscape of Cancer-Application Potential of Flavonoids in the Prevention and Treatment of Cancer.Front Oncol2021https://conductscience.org/library/papers/34235089PubMed
2039061884Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer.Antioxidants (Basel)2024https://conductscience.org/library/papers/39061884PubMed

See all 152 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42891767Phytochemical modulation of DNMT1-mediated DNA methylation: computational insights into breast cancer.J Mol Model2026https://conductscience.org/library/papers/42891767PubMed
42396658ABCG2 transporter: Structural and functional associations with gout (Review).Int J Mol Med2026https://conductscience.org/library/papers/42396658PubMed
42356528Natural Products as Promising Pharmacological Agents Against Cancer: A Holistic Overview of Their Anti-Cancer Mechanisms of Action of the Last Five Years.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42356528PubMed
42243927Histone modifications across cancers: mechanisms, therapy and clinical translation.Mol Cancer2026https://conductscience.org/library/papers/42243927PubMed
42144517Introduction to Cancer Metabolism.Cancer Treat Res2026https://conductscience.org/library/papers/42144517PubMed
41966661Pyroptosis as a double-edged sword in colorectal cancer: Molecular mechanisms and therapeutic opportunities.Apoptosis2026https://conductscience.org/library/papers/41966661PubMed
41752208Suppressive Potential of Ethanolic Extracts of Parkia speciosa Hassk. Empty Pods Against Colon Cancer Cell Migration and Invasion.Int J Mol Sci2026https://conductscience.org/library/papers/41752208PubMed
41751166Diet-Driven Epigenetic Alterations in Colorectal Cancer: From DNA Methylation and microRNA Expression to Liquid Biopsy Readouts.Biomedicines2026https://conductscience.org/library/papers/41751166PubMed
41714725Epigenetic regulation of NDGA and its synergistic inhibition with EZH2 inhibitors in prostate cancer via NRP1.Acta Pharmacol Sin2026https://conductscience.org/library/papers/41714725PubMed
41439968Plant-Derived Antioxidants as Modulators of Redox Signaling and Epigenetic Reprogramming in Cancer.Cells2025https://conductscience.org/library/papers/41439968PubMed
41249064Anticancer potential of dietary fiber for colorectal carcinoma: a narrative review.Ann Med2025https://conductscience.org/library/papers/41249064PubMed
41155893Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer.Pharmaceutics2025https://conductscience.org/library/papers/41155893PubMed
41154590Anticancer Activity of Jania rubens in HCT-116 Cells via EMT Suppression, TET Downregulation, and ROS-Mediated Cytotoxicity.Biomolecules2025https://conductscience.org/library/papers/41154590PubMed
41020873Crosstalk Between Metabolic Reprogramming and Epigenetic Modifications in Colorectal Cancer: Mechanisms and Clinical Applications.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41020873PubMed
40909922Role of curcumin in altering gut microbiota for anti-obesity and anti-hyperlipidemic effects.Front Microbiol2025https://conductscience.org/library/papers/40909922PubMed
40807355Nano-Phytomedicine: Harnessing Plant-Derived Phytochemicals in Nanocarriers for Targeted Human Health Applications.Molecules2025https://conductscience.org/library/papers/40807355PubMed
40733011Acceptability of a Colorectal Cancer-Preventive Diet Promoting Red Meat Reduction and Increased Fiber and Micronutrient Intake: A Cross-Sectional Study in Romanian Adults.Nutrients2025https://conductscience.org/library/papers/40733011PubMed
40663150Epi-nutrients for cancer prevention: Molecular mechanisms and emerging insights.Cell Biol Toxicol2025https://conductscience.org/library/papers/40663150PubMed
40649998Occurrence, Biosynthesis, and Health Benefits of Anthocyanins in Rice and Barley.Int J Mol Sci2025https://conductscience.org/library/papers/40649998PubMed
40467942Advancing the potential of nanoparticles for cancer detection and precision therapeutics.Med Oncol2025https://conductscience.org/library/papers/40467942PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40239010

GET https://conductscience.org/api/papers/v1/40239010/references?page=2